TSBX - Turnstone Biologics Corp.
0.3399
-0.010 -2.971%
Share volume: 269,001
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.35
-0.01
-0.03%
Summary score
35%
Profitability
43%
Dept financing
7%
Liquidity
53%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.53%
Return on assets
-30.72%
Return on sales
0%
Return on invested capital
606.39%
Total debt ratio
22.63%
Debt ratio change over timeo
-0.96%
Current Ratio
4.64%
Quick Ratio
6.72%
Cash Position Ratio
3.01%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-35.23%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
24.96%
Debt ratio change over timeo
-0.96%
Current Ratio
4.04%
Quick Ratio
0%
Cash Position Ratio
2.06%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-42.75%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
27.62%
Debt ratio change over time
0%
Current Ratio
3.7%
Quick Ratio
0%
Cash Position Ratio
3.01%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-104.57%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
-96.32%
Debt ratio change over time
-0.96%
Current Ratio
-0.28%
Quick Ratio
0%
Cash Position Ratio
-0.82%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TSBX | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -24.53% | 18.97% | 6.3% | 14.13% |
| Return on assets | -30.72% | 3.05% | 3.04% | 13.28% |
| Return on sales | 0% | 29.08% | 27.81% | 1.7% |
| Return on invested capital | 606.39% | 5.17% | 3.5% | -46.9% |
| Profitability | 25% | 56% | 38% | 45% |
| Total debt ratio | 22.63% | 92.73% | 66.91% | 19.17% |
| Debt ratio change over time | -0.96% | 21.88% | 144.36% | -1.07% |
| Dept financing | 6% | 29% | 43% | 5% |
| Current Ratio | 4.04% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 2.06% | 0.44% | 0.54% | 0% |
| Liquididy | 58% | 16% | 12% | 75% |
| Short-term ratios | TSBX | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -35.23% | 2.68% | 3.48% | 0% |
| Return on sales | 0% | 21.68% | 28.93% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 38% | 50% | 0% |
| Total debt ratio | 24.96% | 92.96% | 66.32% | 0% |
| Debt ratio change over time | -0.96% | 0% | 0% | 0% |
| Dept financing | 7% | 25% | 43% | 0% |
| Current Ratio | 4.04% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 2.06% | 0.44% | 0.54% | 0% |
| Liquididy | 50% | 33% | 40% | 0% |
